Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05325853 · ClinicalTrials.gov registry record · Phase 3

A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population

A Phase 3 study of Anesthesia, Local, sponsored by American Genomics.

Completed
Registry status
Phase 3
Development phase
61
Enrollment target
1
Study location

NCT05325853 is a Phase 3 study of Anesthesia, Local that has completed, run by American Genomics. The registered enrollment target is 61 participants, below the 80-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05325853, a Phase 3 study of Anesthesia, Local, has completed, sponsored by American Genomics.

COMPLETED
Registry status
Phase 3
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

A Phase 3, randomized, active-controlled, study in pediatric subjects. It is designed to evaluate the safety and anesthetic efficacy of one dose of AG-920 ophthalmic solution compared to Proparacaine Hydrochloride Ophthalmic Solution.

Conditions Studied

Interventions

  • DRUG Proparacaine Ophthalmic
  • DRUG AG-920

Study Locations (1)

Texas

  • American Genomics Site 2 - McAllen

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2022-04-06
Est. Completion 2022-05-27
Phase Phase 3

Sponsor

American Genomics

5 total trials

What the Registry Record Tells You About NCT05325853

The ClinicalTrials.gov registry entry for NCT05325853 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 18 other Anesthesia, Local trials with a reported enrollment target (24% lower). The listed sponsor is American Genomics, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anesthesia, Local appearing as the primary indexed condition, and to 2 interventions - of which Proparacaine Ophthalmic is the first listed.

NCT05325853 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05325853 about?

NCT05325853 is a clinical study titled "A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population". A Phase 3, randomized, active-controlled, study in pediatric subjects. It is designed to evaluate the safety and anesthetic efficacy of one dose of AG-920 ophthalmic solution compared to Proparacaine Hydrochloride Ophthalmic Solution.

What is the current status of trial NCT05325853?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 61 participants. The study started on 2022-04-06. Estimated completion is 2022-05-27.

What conditions does trial NCT05325853 study?

This clinical trial studies the following conditions: Anesthesia, Local.

What interventions are being tested in trial NCT05325853?

The interventions under investigation include: Proparacaine Ophthalmic (DRUG), AG-920 (DRUG).

Who is sponsoring clinical trial NCT05325853?

This trial is sponsored by American Genomics, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05325853 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia, Local

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.